Startups

Slate Bio logo

Slate Bio

Develops regulatory T-cell therapies for autoimmune diseases. A University of Virginia spinout, it works on treatments that restore immune regulation rather than broadly suppressing the immune system.

Founded 2020

Team

Andrew KrousePresident and CEO

Investments

$—Unknown dateEpidarex Capital